Introduction:

Product claims are one of the most sensitive regulatory elements in healthcare-related products. Whether pharmaceutical, cosmetic, or medical device, the wording used on labels, packaging, promotional materials, and advertisements directly impacts product classification, approval pathways, and legal exposure.

The Egyptian Drug Authority (EDA) Claim Guideline establishes a clear regulatory framework governing acceptable and unacceptable claims within the Egyptian market.

This article explores the regulatory foundations of product claims and what manufacturers must understand before entering the Egyptian market.

What Is a “Claim”?

A claim is any statement, representation, or implication regarding a product’s:

Function
Performance
Safety
Efficacy
Therapeutic benefit
Cosmetic effect
Comparative superiority

Claims may appear in:

Product labels
IFUs (Instructions for Use)
Brochures
Websites
Social media campaigns
Distributor materials

Under EDA rules, all claims must be:

Scientifically substantiated
Consistent with product classification
Supported by documented evidence

Why Claims Matter in Regulatory Classification

A single claim can change the regulatory category of a product.
For example:
A cosmetic claiming “moisturizes skin” may remain cosmetic.
The same product claiming “treats eczema” may be classified as a pharmaceutical product.

Improper claims can result in:

Reclassification
Suspension of marketing
Legal liability
Administrative penalties

Key Regulatory Principles from the Guideline

The EDA requires that:

1- Claims must be truthful and not misleading.
2- Claims must be supported by scientific evidence.
3- Claims must not exaggerate product capabilities.
4- Claims must align with approved indications.
5- Comparative claims must be evidence-based and fair.

Manufacturers are responsible for ensuring that distributors and marketing partners comply with these requirements.

Regulatory Risk for Manufacturers

Non-compliant claims may result in:
Product withdrawal
Suspension of registration
Administrative fines
Market reputation damage
Legal consequences

This makes internal claim review procedures essential.

Conclusion:

The EDA Claim Guideline reinforces that regulatory compliance does not stop at product approval – it extends into marketing communication. A structured claim review process is now a necessity for companies operating in Egypt.

Proactive compliance protects both brand and long-term market access.